This inventor holds 57 USPTO granted patents and 5 published patent applications and 6 EPO patents, primarily in Tissue Engineering (CPC class 1282). Top assignees: Medi-Ject Corporation, Tissuemill Technologies LLC, Tenax Corporation. Active years: 1991-2026.
Inventors with similar research interests:
Company Filing History:
7 out of 14Â 
7 out of 7Â 
5 out of 23Â 
Years Active: 1991-2026
Areas of Expertise:
Certainly! Here is a draft of the article about inventor Paul Mulhauser:
Title: Innovator Spotlight: Paul Mulhauser - Revolutionizing Tissue Preparation and Treatment
Introduction:
In the bustling city of New York, NY, renowned inventor Paul Mulhauser has made a significant impact in the field of medical innovations. With a remarkable portfolio of 52 patents under his name, Mulhauser's contributions have been nothing short of revolutionary.
Latest Patents:
Mulhauser's latest groundbreaking patents focus on atraumatically formed tissue compositions, devices, and methods of preparation and treatment. The innovative process and system he has developed allow for the atraumatic preparation of morselized Tissue Particles (TPs) in a liquid medium. This includes Full Thickness Skin Graft Particles (FTSGPs), cartilage particles, and other organ tissue particles, all suspended in an aqueous solution. These highly viable cell-containing tissue products can be rapidly prepared and conveniently delivered to patients, catering to various surgical applications such as wound healing, cosmetic surgery, and orthopedic cartilage repairs.
Career Highlights:
Throughout his illustrious career, Mulhauser has left his mark on notable companies such as Medi-ject Corporation and Tenax Corporation. His innovative prowess and dedication to advancing medical technologies have earned him a reputation as a visionary in the industry.
Collaborations:
In his collaborative endeavors, Mulhauser has worked alongside esteemed colleagues like David R. Schiff and Karl D. Kirk. Together, they have furthered the boundaries of medical innovation, pushing the envelope of what is possible in the realm of tissue preparation and treatment.
Conclusion:
In conclusion, Paul Mulhauser's relentless commitment to pushing the boundaries of medical innovation shines through in his remarkable body of work. His dedication to atraumatically formed tissue compositions has opened up new possibilities in the field, promising a future where surgical procedures are safer, more efficient, and ultimately more effective in benefiting patients worldwide.
If you need any further assistance or modifications to the article, feel free to let me know!